Cardiovascular events ceramides. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Epidermis Brachial Artery Carotid Arteries Tunica Media Ankle Endothelium, Vascular Tunica Intima Skin Cardiovascular System Coronary Vessels Femoral Artery Cells, Cultured

Organisms1

Diseases53

Cardiovascular Diseases Myocardial Infarction Stroke Coronary Artery Disease Hypertension Acute Coronary Syndrome Coronary Disease Diabetes Mellitus, Type 2 Atherosclerosis Diabetic Angiopathies Kidney Failure, Chronic Renal Insufficiency, Chronic Peripheral Vascular Diseases Plaque, Atherosclerotic Calcinosis Angina Pectoris Diabetes Complications Lipidoses Kidney Diseases Death, Sudden, Cardiac Heart Failure Carotid Artery Diseases Dyslipidemias Recurrence Disease Progression Death Albuminuria Peripheral Arterial Disease Thrombosis Metabolic Syndrome X Hypertrophy, Left Ventricular Hypercholesterolemia Angina, Unstable Myocardial Ischemia Diabetes Mellitus Vascular Calcification Inflammation Insulin Resistance Chronic Disease Coronary Stenosis Heart Diseases Hyperlipidemias Aortic Diseases Cerebrovascular Disorders Arteriosclerosis Sphingolipidoses White Coat Hypertension Arteriosclerosis Obliterans Obesity Diabetic Nephropathies Intermittent Claudication Hemorrhage Atrial Fibrillation

Chemicals and Drugs80

Ceramides Sphingolipids Sphingomyelins Glucosylceramides Alkaline Ceramidase Sphingosine Sphingomyelin Phosphodiesterase Cerebrosides Sphingosine N-Acyltransferase Biological Markers Ceramidases Hydroxymethylglutaryl-CoA Reductase Inhibitors Serine C-Palmitoyltransferase C-Reactive Protein Platelet Aggregation Inhibitors Antihypertensive Agents Glycosphingolipids Lipids Heptanoic Acids Pravastatin Aspirin I Blood-Group System Anticholesteremic Agents Cholesterol, LDL Pyrroles Ticlopidine Fluorobenzenes Fatty Acids Hypolipidemic Agents Fumonisins Acid Ceramidase Natriuretic Peptide, Brain Neutral Glycosphingolipids Cholesterol Chlorthalidone Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents Sulfoglycosphingolipids Cholesterol, HDL Fosinopril Hydroxy Acids Cystatin C Amlodipine Amino Alcohols Glycolipids Lysophospholipids 1-Alkyl-2-acetylglycerophosphocholine Esterase Angiotensin II Type 1 Receptor Blockers Simvastatin Creatinine Phospholipases A2, Secretory G(M3) Ganglioside Diglycerides Atenolol Glucosylceramidase Tetrazoles Niacin Perindopril Hypoglycemic Agents Fatty Alcohols Galactosylceramides Galactosylgalactosylglucosylceramidase Triglycerides Azetidines Cyclooxygenase 2 Inhibitors Oxidoreductases Ramipril Sulfonamides Neutral Ceramidase Lipid Bilayers Blood Glucose Benzimidazoles Phospholipase D Lactosylceramides Fibrinogen Amidohydrolases Glucosyltransferases Particulate Matter Glycerophospholipids Hemoglobin A, Glycosylated

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Risk Factors Follow-Up Studies Prospective Studies Proportional Hazards Models Predictive Value of Tests Risk Assessment Incidence Prognosis Treatment Outcome Chromatography, Thin Layer Cohort Studies Kaplan-Meier Estimate Blood Pressure Randomized Controlled Trials as Topic Double-Blind Method Risk Renal Dialysis Chromatography, Gas Multivariate Analysis Coronary Angiography Drug Therapy, Combination Severity of Illness Index Angioplasty, Balloon, Coronary Chi-Square Distribution Retrospective Studies Blood Pressure Monitoring, Ambulatory Ankle Brachial Index Carotid Intima-Media Thickness Glomerular Filtration Rate Survival Rate Cause of Death Survival Analysis Endpoint Determination Odds Ratio Hospitalization Myocardial Revascularization Logistic Models Percutaneous Coronary Intervention Case-Control Studies Prevalence ROC Curve Disease-Free Survival Regression Analysis Mass Spectrometry Platelet Function Tests Electrocardiography Longitudinal Studies Stents Spectrometry, Mass, Electrospray Ionization Blood Pressure Determination Cross-Sectional Studies Propensity Score Spectrophotometry, Infrared X-Ray Diffraction Spectrometry, Mass, Fast Atom Bombardment Coronary Artery Bypass Registries Obesity Drug Chronotherapy Pulse Wave Analysis Kidney Function Tests Heart Rate Epidemiologic Methods Mortality Analysis of Variance Estrogen Replacement Therapy Tomography, X-Ray Computed Multicenter Studies as Topic

Psychiatry and Psychology1

Phenomena and Processes22

Time Factors Blood Pressure Risk Water Loss, Insensible Lipid Metabolism Chi-Square Distribution Carotid Intima-Media Thickness Glomerular Filtration Rate Odds Ratio Insulin Resistance Molecular Structure Vascular Stiffness Circadian Rhythm Apoptosis Vasodilation Dose-Response Relationship, Drug Optical Rotation X-Ray Diffraction Pulsatile Flow Obesity Hydrolysis Heart Rate

Technology, Industry, Agriculture1

Information Science6

Incidence Survival Rate Cause of Death Prevalence Registries Mortality

Health Care41

Risk Factors Follow-Up Studies Prospective Studies Proportional Hazards Models Predictive Value of Tests Risk Assessment Incidence Treatment Outcome Cohort Studies Kaplan-Meier Estimate Randomized Controlled Trials as Topic Double-Blind Method Risk Multivariate Analysis Primary Prevention Secondary Prevention Severity of Illness Index Comorbidity Chi-Square Distribution Retrospective Studies Survival Rate Cause of Death Survival Analysis Odds Ratio Hospitalization Age Factors Logistic Models Case-Control Studies Prevalence ROC Curve Disease-Free Survival Regression Analysis Sex Factors Longitudinal Studies Cross-Sectional Studies Propensity Score Registries Epidemiologic Methods Mortality Analysis of Variance Multicenter Studies as Topic

Geographicals4

Japan United States Germany Italy

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care Geographicals

Ceramides Cardiovascular Diseases Sphingolipids Risk Factors Follow-Up Studies Sphingomyelins Glucosylceramides Alkaline Ceramidase Myocardial Infarction Sphingosine Prospective Studies Sphingomyelin Phosphodiesterase Proportional Hazards Models Stroke Cerebrosides Coronary Artery Disease Predictive Value of Tests Sphingosine N-Acyltransferase Risk Assessment Biological Markers Ceramidases Hydroxymethylglutaryl-CoA Reductase Inhibitors Incidence Prognosis Serine C-Palmitoyltransferase Hypertension Treatment Outcome C-Reactive Protein Chromatography, Thin Layer Acute Coronary Syndrome Cohort Studies Kaplan-Meier Estimate Platelet Aggregation Inhibitors Time Factors Antihypertensive Agents Coronary Disease Glycosphingolipids Lipids Diabetes Mellitus, Type 2 Epidermis Heptanoic Acids Blood Pressure Randomized Controlled Trials as Topic Atherosclerosis Pravastatin Double-Blind Method Risk Diabetic Angiopathies Kidney Failure, Chronic Aspirin I Blood-Group System Anticholesteremic Agents Renal Insufficiency, Chronic Cholesterol, LDL Renal Dialysis Chromatography, Gas Pyrroles Japan Ticlopidine Peripheral Vascular Diseases Plaque, Atherosclerotic Calcinosis Fluorobenzenes Angina Pectoris Multivariate Analysis Brachial Artery Primary Prevention Coronary Angiography Water Loss, Insensible Fatty Acids Diabetes Complications Secondary Prevention Lipidoses Hypolipidemic Agents Fumonisins Acid Ceramidase Kidney Diseases Natriuretic Peptide, Brain Death, Sudden, Cardiac Heart Failure Drug Therapy, Combination Lipid Metabolism Neutral Glycosphingolipids Cholesterol Severity of Illness Index Carotid Artery Diseases Comorbidity Chlorthalidone Carotid Arteries Angioplasty, Balloon, Coronary Dyslipidemias Chi-Square Distribution Angiotensin-Converting Enzyme Inhibitors Retrospective Studies Blood Pressure Monitoring, Ambulatory Cardiovascular Agents Sulfoglycosphingolipids Recurrence Disease Progression Cholesterol, HDL

No FAQ available that match "cardiovascular events ceramides"